Clinical Trial Update: Effect of Doxium on High Sensitivity CRP and Endothelin-1 Serum Levels in Patients With Diabetic Retinopathy [Phase 4]

View source ↗

Summary

Clinical trial update on a Phase 4 study evaluating the effect of Doxium on high-sensitivity C-reactive protein and endothelin-1 serum levels in patients with d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Retinopathy

Drugs mentioned

• Doxium

Snippet

Sponsor: Tabriz University | Conditions: Diabetic Retinopathy | Phase 4 | Status: UNKNOWN